Breaking News -- FDA Issues Warning on Several Proton Pump Inhibitors

Posted by
Yesterday, the US-FDA issued a new warning on several popular proton pump inhibitors (PPI). The agency warned that the use of certain heartburn and acid reflux drugs might increase the risk of Clostridium difficile-associated diarrhea (CDAD). In addition, the agency also suggested diagnosis of CDAD for patients who are taking PPIs and developed diarrhea that does not improve.


The FDA issued this safety announcement just after the review of reports from the AERS (Adverse Event Reporting System) and the medical literature suggested such a link with PPIs.

According to MedPage Today, the warning applies to the following both prescription and over-the-counter PPIs: 
  • omeprazole
  • omeprazole and sodium bicarbonate
  • esomeprazole magnesium
  • pantoprazole sodium
  • rabeprazole sodium
  • lansoprazole
  • dexlansoprazole
Furthermore, you need to know that PPIs have already linked with several other adverse events, including arrhythmias, seizures, clopidogrel resistance, osteoporotic fractures, cardiac birth defects, and decrease in magnesium levels resulting in an increased risk of leg spasms.

The FDA safety announcement also reported that the agency has already started working with these drug manufacturers for modifying the labels to include the warning regarding increased risk of Clostridium difficile-associated diarrhea.


Additionally, you need to know that Clostridium difficile (C. difficile) is a bacterium, which causes a serious diarrhea that rarely improve. 


Symptoms Include:
  • Water like stool
  • Serious intestinal discomforts
  • Pain in abdomen and fever

2 comments:

  1. so seriously as u know it is the best for any sort of gastritis problem, the drug should be modified.

    ReplyDelete

  2. Thanks Sabbir for the comment. Actually, in our country, it just becomes a habit for us to take PPIs in any sort of gastritis problem. However, we need to be cautious when taking these medicines in general acidic conditions.

    ReplyDelete

Subscribe to: Post Comments (Atom)
Related Posts Plugin for WordPress, Blogger...

Donate a Cancer Patient

Help Iftekhar to Raise Fund for his Leukemia

Before last two weeks, Mr. Iftekharul Ibna Alam was a young, energetic and enthusiastic employee of Independent Television, Bangladesh. Professionally, he has more than five years of experience in relation to TV media, and is well versed in broadcasting operations. Still, he is one of the pioneer executives in Bangladesh who has handled multiple automation software. However, life of this gifted and talented "Senior Executive, Presentation" of Independent Television, Bangladesh is in great danger now. Two weeks ago, he was diagnosed with lethal cancerous disease Leukemia (Acute Lymphoblastic Leukemia). Currently, he is admitted in Square Hospitals Ltd, Dhaka, Bangladesh. The initial treatment is already started, but he needs Bone Marrow Transplantation and further treatment, which are not possible in Bangladesh. For this reason, he needs to go aboard. However, you need to know that further treatment of Acute Lymphoblastic Leukemia is still out of range for a person like Iftekhar, because it accounts minimum 6 - 8 million BDT just only in India and in Singapore, the amount may maximize up to 15 - 20 million BDT. In addition, these types of amount are very unbearable for anyone who came from a middle class family like Iftekhar. Moreover, he needs to go aboard for further treatment within a very short time. As a result, his family is now badly engaged in financial crisis and they need financial support. Please step forward to raise fund for this talented individual.

Local Bank Details:

Md. Mohidul Alam, National Bank Ltd, Account no. SB34002372, Ishwardi Branch, Ishwardi.

Md. Mohidul Alam, Prime Bank Ltd Ac. No. 17921020000593 Ishwardi Branch, Ishwardi.

Contact Info:

Mobile: 01711826527, 01737244772, 01917446565 and 01672363848.

Email: danny_alam007@yahoo.com, imtiazdanny@gmail.com and imtiazdanny@medical-reference.net.